Finance

Lists
LFMD:NASDAQ
LifeMD Inc
$3.62
+1.69%
(+0.060) 1D
$3.62
0.00% (0.00)
After hours
Closed: Aug 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LFMD...
Open
$3.50
High
$3.64
Low
$3.41
Mkt. cap
174.49M
Avg. vol.
1.05M
Volume
2.23M
52-wk high
$7.32
52-wk low
$2.56
EPS
-$0.06
Beta
2.02
Shares outstanding
48.20M
No. of employees
350
Open
$3.50
High
$3.64
Low
$3.41
Mkt. cap
174.49M
Avg. vol.
1.05M
Volume
2.23M
52-wk high
$7.32
52-wk low
$2.56
EPS
-$0.06
Beta
2.02
Shares outstanding
48.20M
No. of employees
350
News stories
From web sources and news partners
Profile
LifeMD, Inc. is a publicly traded American telehealth company. It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications. Wikipedia
About LifeMD Inc
CEO-
Employees350
FoundedMay 24, 1994
Headquarters-
SectorHealth care
Websitelifemd.com
Analyst ratings
Based on 7 analysts giving stock ratings to LFMD in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for LFMD in the last 3 months.
Highest
Current $3.62
$15.00 (+314.36%)
Average
$8.29 (+129.01%)
Lowest
$5.00 (+38.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Schoenhaus
KeyBanc
Buy
Maintained
$5.00
+38.1%
08/07/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$9.00
+148.6%
08/07/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
$8.00
+121%
08/06/2026
Ryan Meyers
Lake Street
Buy
Maintained
$5.00
+38.1%
08/06/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
$15.00
+314.4%
08/05/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$7.00
+93.4%
08/06/2026
David Larsen
BTIG
Buy
Reiterated
$9.00
+148.6%
08/06/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
$15.00
+314.4%
08/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
60.17M
46.87M
50.16M
47.28M
Cost of goods sold
7.41M
6.03M
5.93M
5.28M
Cost of revenue
7.41M
6.03M
5.93M
5.28M
Research and development expenses
2.85M
1.82M
1.80M
1.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.26M
37.12M
48.56M
44.67M
Operating expense
54.73M
41.94M
53.17M
49.13M
Total operating expenses
62.14M
47.97M
59.09M
54.41M
Operating income
-1.97M
-1.10M
-8.93M
-7.13M
Other non operating income
-
-
-
-
EBT including unusual items
-3.39M
-1.07M
-8.87M
-7.08M
EBT excluding unusual items
-2.23M
-1.07M
-8.87M
-7.08M
Income tax expense
169.13K
13.90K
-
-
Effective tax rate
-4.99%
-1.29%
-
-
Other operating expenses
2.62M
3.00M
2.81M
2.67M
Net income
-3.81M
19.96M
-8.87M
-7.08M
Net profit margin
-6.33%
42.59%
-17.69%
-14.98%
Earnings per share
-0.08
0.06
-0.15
-0.15
Interest and investment income
-
24.08K
56.48K
45.66K
Interest expense
-262.46K
-
-
-
Net interest expenses
-262.46K
24.08K
56.48K
45.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.44M
-784.19K
-8.61M
-6.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps